| Literature DB >> 23228040 |
Feng-Jui Chen1, Leung-Kei Kristopher Siu, Jung-Chung Lin, Chen-Her Wang, Po-Liang Lu.
Abstract
BACKGROUND: Compared to methicillin-resistant Staphylococcus aureus (MRSA), characteristics of nasal carriage and community-onset infection methicillin-susceptible S. aureus (MSSA) are less well known. No characteristics of MSSA in Taiwan have been reported previously.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23228040 PMCID: PMC3522061 DOI: 10.1186/1471-2334-12-343
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1PFGE dendrogram with molecular characterization for 100 nasal carriage and 34 infection MSSA isolates. PFGE cluster was assigned to isolates having 80% or greater similarity from the dendrograms (A similarity cut-off of 70% was also presented.). Multi-locus sequence typing (MLST), results in sequence type (ST); clonal complexes (CC); * Panton-Valentine leukocidin (PVL)-positive.
Clinical characteristics of patients with community-associated and healthcare-associated community-onset infection
| Community-associated infection (24) | A:45 (1) | ST508 | Cellulitis | |
| B:6 (1) | ST6 | | Osteomyelitis | |
| C:7 (3) | ST7 | Cellulitis (1) | Pneumonia (1), spondylitis (1) | |
| C:12 (3) | ST12 | | Necrotizing mediastinitis (1), acute cholecystitis (1), spondylitis (1) | |
| D:1 (5) | ST188 | Urinary tract infection (1) | Spondylitis (1), paraspinal abscess (1), septic arthritis (1), pneumonia (1) | |
| E:97 (3) | ST97 | Cellulitis (1) | Septic arthritis (1), endocarditis (1) | |
| G:15 (2) | ST15 | Cellulitis (2) | | |
| J:398 (1) | ST291 | | Septic arthritis | |
| N:59 (2) | ST59 | Cellulitis (2) | | |
| P:8 (1) | ST630 | | Epiglotitis with septicemia | |
| Q (1) | NT | | Pneumonia | |
| R (1) | NT | | Pneumonia | |
| Healthcare-associated community-onset infection (10) | C:6 (1) | ST6 | | Pneumonia |
| C:7 (3) | ST7 | Wound (2) | CNS infection (1) | |
| C:12 (1) | ST12 | Wound | | |
| D:1 (2) | ST188 | Epidermal cyst (1), wound (1) | | |
| E:97 (1) | ST97 | | Septic arthritis | |
| G:15 (1) | ST15 | | Bacteremia | |
| N:59 (1) | ST59 | Wound | ||
PFGE: pulsed-field gel electrophoresis.
MLST: multi-locus sequence typing.
NT: non-typable.
* representative STs.
# the number in parenthesis represents the number of isolates.
Figure 2Phylogenetic tree of the types was constructed by using MEGA version 5. The tree was produced based on the cost matrix for the distances of spa types. The cost “6” parameter for the BURP clustering was used in this figure. The circle indicates the major infection PFGE cluster. spa-CCs and the represented ST (CC) are indicated. NF (no founder) indicates clusters without group founders.
Comparison of virulence gene profiles among nasal carriage and infection isolates
| 91 | 91 | 33 | 97.1 | 3.264 | 0.206-51.833 | 0.271 | |
| 58 | 58 | 14 | 41.2 | 0.507 | 0.179-1.432 | 0.092 | |
| 100 | 100 | 34 | 100 | | | | |
| 59 | 59 | 20 | 58.8 | 0.993 | 0.351-2.806 | 0.986 | |
| 72 | 72 | 24 | 70.6 | 0.933 | 0.303-2.879 | 0.875 | |
| 23 | 23 | 2 | 5.9 | 0.209 | 0.029-1.507 | 0.041 | |
| 97 | 97 | 34 | 100 | | | | |
| 14 | 14 | 6 | 17.6 | 1.316 | 0.332-5.212 | 0.607 | |
| 29 | 29 | 6 | 17.6 | 0.525 | 0.144-1.907 | 0.198 | |
| 26 | 26 | 4 | 11.8 | 0.379 | 0.085-1.686 | 0.094 | |
| 0 | 0 | 0 | 0 | | | | |
| 0 | 0 | 0 | 0 | | | | |
| 37 | 37 | 12 | 35.3 | 0.929 | 0.319-2.700 | 0.858 | |
| 0 | 0 | 0 | 0 | | | | |
| 20 | 20 | 1 | 2.9 | 0.121 | 0.008-1.790 | 0.044 | |
| 12 | 12 | 0 | 0 | | | | |
| 7 | 7 | 3 | 8.8 | 1.286 | 0.201-8.226 | 0.727 | |
| 97 | 97 | 33 | 97.1 | 1.021 | 0.050-20.899 | 0.986 | |
| 31 | 31 | 8 | 23.5 | 0.685 | 0.210-2.231 | 0.409 | |
| 100 | 100 | 34 | 100 | | | | |
Comparison of resistance rates (%) for nasal carriage and infection isolates
| Chloramphenicol | 10 (10%) | 3 (9%) | 1 |
| Ciprofloxacin | 0 | 0 | |
| Clindamycin | 13 (13%) | 3 (9%) | 0.56 |
| Erythromycin | 46 (46%) | 3 (9%) | |
| Gentamicin | 0 | 2 (6%) | 0.07 |
| Linezolid | 0 | 0 | |
| Oxacillin | 0 | 0 | |
| Penicillin | 92 (92%) | 31 (91%) | 0.73 |
| QDA | 0 | 0 | |
| Rifampin | 1 (1%) | 0 | 1 |
| SXT | 0 | 0 | |
| Teicoplanin | 0 | 0 | |
| Tetracycline | 36 (36%) | 14 (41%) | 0.92 |
| Vancomycin | 0 | 0 |
QDA: Quinupristin/dalfopristin.
SXT: Trimethoprim/sulfamethoxazole.